Intuitive Surgical (ISRG) Prelim. Q4 Revenue Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- Wall Street ends higher as Amazon soothes AI jitters
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Intuitive Surgical (ISRG) PT Raised to $465 at Barclays Following Q4 Earnings Report
January 11, 2018 3:46 AM ESTBarclays raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $465.00 (from $390.00) while maintaining a Overweight rating.
Analyst Matt Taylor comments "We view system placements as one sign of a stable capital purchasing environment and ISRG does not appear... More
